M. Lia Palomba

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 34 papers. Top paper: “SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas”.

SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas

Blood Cancer Journal(2020)10.1038/s41408-020-0277-6

N/A

1.4DataRank · unranked

48 citations

Xia Liu, Jiaji G. Chen, Lian Xu, Nickolas Tsakmaklis, Maria Demos +19 more

TP53mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

Blood Advances(2023)10.1182/bloodadvances.2023009953

N/A

0.505DataRank · unranked

28 citations

Nivetha Ganesan, Zachary D. Epstein‐Peterson, Alison J. Moskowitz, Robert Stuver, Catherine Maccaro +27 more

Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.08.001

N/A

0.496DataRank · unranked

9 citations

Ana Alarcón Tomás, Jessica Flynn, Joshua Fein, Anna Alperovich, Theodora Anagnostou +19 more

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010003

N/A

0.470DataRank · unranked

22 citations

Soo‐Jeong Kim, Samantha Brown, Theresa A. Elko, Josel D. Ruiz, Danielle M Hanley +19 more

Atrial arrhythmias following CAR‐chimeric antigen receptor T‐cell therapy: Incidence, risk factors and biomarker profile

British Journal of Haematology(2024)10.1111/bjh.19497

N/A

0.434DataRank · unranked

17 citations

Adam Goldman, Jessica Flynn, Ahmed El‐Moghraby, Mahin Rehman, Sean M. Devlin +20 more

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas

Blood Advances(2022)10.1182/bloodadvances.2021006147

N/A

0.416DataRank · unranked

15 citations

Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Maria Luisa Guerrera, Zachary R. Hunter +18 more

Dynamics of Immune Reconstitution and Impact on Outcomes across CAR-T Cell Products in Large B-cell Lymphoma

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-24-0163

N/A

0.396DataRank · unranked

13 citations

Susan DeWolf, Teng Fei, Sandeep Raj, Gunjan L. Shah, Caleb A. Lareau +18 more

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma

Blood Cancer Journal(2022)10.1038/s41408-022-00620-w

N/A

0.291DataRank · unranked

5 citations

Michelle Okwali, Anna Alperovich, Philip Caron, Lorenzo Falchi, Audrey Hamilton +22 more

Retrospective characterization of nodal marginal zone lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009587

N/A

0DataRank · unranked

8 citations

Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip Caron +24 more

Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01540-x

N/A

0DataRank · unranked

39 citations

Jessica Flynn, Sean M. Devlin, Audrey Mauguen, Teng Fei, Shang Zeng +23 more

Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.027

N/A

0DataRank · unranked

13 citations

Roni Shouval, Jessica Flynn, Sean M. Devlin, Amethyst Saldia, Alejandro Luna +16 more

Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective Cohort

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.10.010

N/A

0DataRank · unranked

12 citations

Alejandro Luna, Gunjan L. Shah, Sean M. Devlin, Magdalena Corona, Joshua Fein +13 more

Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes

Blood Advances(2024)10.1182/bloodadvances.2024014555

N/A

0DataRank · unranked

13 citations

Sean Devlin, Roni Shouval, Kai Rejeski, Magdalena Corona, Alejandro Luna +15 more

Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis

Haematologica(2024)10.3324/haematol.2023.284179

N/A

0DataRank · unranked

8 citations

Zachary D. Epstein‐Peterson, Nivetha Ganesan, Timothy Pak, Tiffany Chang, Phuong Dao +21 more

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Blood Cancer Journal(2024)10.1038/s41408-024-01148-x

N/A

0DataRank · unranked

3 citations

Efrat Luttwak, Alfredo Rivas‐Delgado, Helen Irawan, Alexander P. Boardman, Philip Caron +26 more

CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas

Blood Neoplasia(2024)10.1016/j.bneo.2024.100031

N/A

0DataRank · unranked

1 citations

Kurt S. Bantilan, Erel Joffe, M. Lia Palomba, Ariela Noy, Philip Caron +12 more

Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma

Research Square(2024)10.21203/rs.3.rs-4619285/v1

N/A

0DataRank · unranked

2 citations

M. Lia Palomba, Karlo Perica, Sean M. Devlin, Gunjan L. Shah, Parastoo B. Dahi +28 more

T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

Blood(2025)10.1182/blood.2025028833

N/A

0DataRank · unranked

34 citations

Jaime Sanz, Teng Fei, Monica Nair, Hamza Hashmi, Abraham Avigdor +32 more

Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies

Blood Cancer Journal(2025)10.1038/s41408-025-01321-w

N/A

0DataRank · unranked

11 citations

Stephanie Lobaugh, Danny Luan, Marina Gómez-Llobell, P Subramanian, Sean M. Devlin +22 more

Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01338-1

N/A

0DataRank · unranked

8 citations

Sandeep Raj, Michael D. Jain, Gloria Iacoboni, Fabian Müller, Leo Hansmann +26 more

Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma

Bone Marrow Transplantation(2025)10.1038/s41409-025-02519-z

N/A

0DataRank · unranked

5 citations

Andrew Ip, Samantha Brown, Alejandro Luna, Hazim Khatib, Jessica Flynn +22 more

CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01273-1

N/A

0DataRank · unranked

4 citations

Sean M. Devlin, Kai Rejeski, Jessica Flynn, Magdalena Corona, Efrat Luttwak +21 more

Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma

Haematologica(2025)10.3324/haematol.2024.286813

N/A

0DataRank · unranked

1 citations

Manik Uppal, Serena Zheng, Kurt S. Bantilan, Connie Lee Batlevi, Zachary D. Epstein‐Peterson +21 more

142 | LISOCABTAGENE MARALEUCEL IN R/R FL (TRANSCEND FL): IMPACT OF PRIOR LINES OF THERAPY, BENDAMUSTINE EXPOSURE, AND DISEASE PROGRESSION ≤ 24 MONTHS OF INITIAL SYSTEMIC THERAPY

Hematological Oncology(2025)10.1002/hon.70093_142

N/A

0DataRank · unranked

0 citations

Juan Luis Reguera Ortega, Franck Morschhauser, Guillaume Cartron, Aaron P. Rapoport, Koji Izutsu +14 more

Dermatologic Adverse Events Following CD19-Directed CAR T-Cell Therapy in Hematologic Malignancies

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.09.012

N/A

0DataRank · unranked

0 citations

Rachel Reingold, Rose Parisi, Stephen W. Dusza, Sarah Noor, Jae H. Park +9 more

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

Blood Cancer Journal(2020)10.1038/s41408-020-00346-7

N/A

0DataRank · unranked

264 citations

M. Lia Palomba, Martina Pennisi, Marta García‐Recio, Jessica Flynn, Sean M. Devlin +13 more

Antibody Titers of Vaccine-Preventable Pathogens at 1 Year Post CD19 CAR-T Cell Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.10.034

N/A

0DataRank · unranked

0 citations

Nishi Shah, Sigrun Einarsdottir, Ana Alarcón Tomás, Meighan Palazzo, Josel D. Ruiz +11 more

Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma

Haematologica(2020)10.3324/haematol.2019.243246

N/A

0DataRank · unranked

58 citations

Stephanie Lobaugh, Martina Pennisi, Hei Ton Chan, Yakup Batlevi, Josel D. Ruiz +20 more

The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy(2020)10.1016/j.jtct.2020.10.022

N/A

0DataRank · unranked

47 citations

Kitsada Wudhikarn, Martina Pennisi, Rosalía Alonso, Jessica Flynn, Roni Shouval +17 more

Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?

Blood Advances(2021)10.1182/bloodadvances.2021004939

N/A

0DataRank · unranked

42 citations

Karen Chau, Jasme Lee, Jisun Lee, Dana L. Casey, Joanna C. Yang +13 more

Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.02.011

N/A

0DataRank · unranked

14 citations

Gunjan L. Shah, Darren R. Feldman, Josel D. Ruiz, Elizabeth Robilotti, Anoshé Aslam +23 more

CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004128

N/A

0DataRank · unranked

36 citations

David Qualls, Sébastien Monette, Shenon Sethi, Ahmet Doǧan, Mikhail Roshal +8 more

CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

Nature Medicine(2023)10.1038/s41591-023-02404-6

N/A

0DataRank · unranked

167 citations

Karthik Nath, Sean M. Devlin, Craig S. Sauter, M. Lia Palomba, Gunjan L. Shah +14 more

Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement

British Journal of Haematology(2023)10.1111/bjh.19037

N/A

0DataRank · unranked

16 citations

Rebecca L. Zon, Robert Redd, David C. Fisher, Roni Shouval, Anita Kumar +12 more